Be Prepared to Discuss Dovato, a New Two-Med Combo for HIV

Dovato (doh-VAH-toh) is the first TWO-med complete HIV regimen in one pill that can be used for treatment-naive patients.

It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.

Dovato will try to compete with other one-pill regimens, such as Biktarvy and Triumeq. These THREE-med, one-pill combos have an integrase TWO nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote